These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 15290423)
21. [Positive microvolt T-wave alternans as a marker of ventricular arrhythmia trigering during cardioverter-defibrillator implantation]. Wierzbowski R; Michałkiewicz D; Cholewa M; Jacewicz K; Gniłka A; Adamus J Pol Merkur Lekarski; 2006 Oct; 21(124):310-3. PubMed ID: 17205766 [TBL] [Abstract][Full Text] [Related]
22. [From implantable cardioverter-defibrillator to cardiac resynchronization therapy with the use of epicardial left ventricular lead. The evolution of the treatment of post inflammatory heart failure--a case report]. Gepner K; Sterliński M; Przybylski A; Maciag A; Kołsut P; Szwed H Kardiol Pol; 2006 Oct; 64(10):1113-7. PubMed ID: 17089244 [TBL] [Abstract][Full Text] [Related]
23. Perforation of the right ventricular free wall by an ICD lead in a patient with isolated noncompaction of the ventricular myocardium. Sakai Y; Sato Y; Matsuo S; Imai S; Kunimasa T; Matsumoto N; Saito S Int J Cardiol; 2007 May; 117(3):e104-6. PubMed ID: 17350119 [TBL] [Abstract][Full Text] [Related]
24. Electrical storm of monomorphic ventricular tachycardia after a cardiac-resynchronization-therapy-defibrillator upgrade. Kantharia BK; Patel JA; Nagra BS; Ledley GS Europace; 2006 Aug; 8(8):625-8. PubMed ID: 16772367 [TBL] [Abstract][Full Text] [Related]
25. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. Haigney MC; Zareba W; Gentlesk PJ; Goldstein RE; Illovsky M; McNitt S; Andrews ML; Moss AJ; J Am Coll Cardiol; 2004 Oct; 44(7):1481-7. PubMed ID: 15464332 [TBL] [Abstract][Full Text] [Related]
26. [Anesthetic management of a hemodialysis-dependent patient for the brain tumor resection with CHDF]. Inaba S; Nishimura N; Matsuda K; Nishino T Masui; 2004 Jan; 53(1):82-5. PubMed ID: 14968611 [TBL] [Abstract][Full Text] [Related]
27. An "aggressive" protocol of programmed ventricular stimulation for selecting post-myocardial infarction patients with a low ejection fraction who may not require implantation of an automatic defibrillator. Belhassen B; Ohayon-Tsioni T; Glick A; Viskin S Isr Med Assoc J; 2009 Sep; 11(9):520-4, 526, 528. PubMed ID: 19960844 [TBL] [Abstract][Full Text] [Related]
28. Anesthetic management for cardioverter-defibrillator implantation in a patient with Kearns-Sayre syndrome. Hara K; Sata T; Shigematsu A J Clin Anesth; 2004 Nov; 16(7):539-41. PubMed ID: 15590260 [TBL] [Abstract][Full Text] [Related]
29. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study. Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310 [TBL] [Abstract][Full Text] [Related]
30. Effect of first ventricular tachycardia cycle length on rate of ventricular arrhythmia recurrence in patients with implantable cardioverter-defibrillator. Arya A; Haghjoo M; Nikoo MH; Dehghani MR; Fazelifar AF; Sadr-Ameli MA J Electrocardiol; 2006 Oct; 39(4):404-8. PubMed ID: 16895771 [TBL] [Abstract][Full Text] [Related]
31. Long-term incidence of malignant ventricular arrhythmia and shock therapy in patients with primary defibrillator implantation does not differ from event rates in patients treated for survived cardiac arrest. Backenköhler U; Erdogan A; Steen-Mueller MK; Kuhlmann C; Most A; Schaefer C; Stertmann W; Waas W; Tillmanns H; Waldecker B J Cardiovasc Electrophysiol; 2005 May; 16(5):478-82. PubMed ID: 15877617 [TBL] [Abstract][Full Text] [Related]
32. Incidence and causes of inappropriate detection and therapy by implantable defibrillators of cardioversion in patients with ventricular tachyarrhythmia. Chen RH; Chen KP; Wang FZ; Hua W; Chen X; Zhang S Chin Med J (Engl); 2006 Apr; 119(7):557-63. PubMed ID: 16620696 [TBL] [Abstract][Full Text] [Related]
33. [Implantable cardioverter-defibrillator in the treatment of two patients with an increased risk of sudden cardiac death]. van den Berg MP; van Tintelen JP; van Dessel PF; van Veldhuisen DJ Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2132-5. PubMed ID: 15553359 [TBL] [Abstract][Full Text] [Related]
35. Fatal outcome from inappropriate defibrillation. Dimitri H; John B; Young GD; Sanders P Europace; 2007 Nov; 9(11):1059-60. PubMed ID: 17827163 [TBL] [Abstract][Full Text] [Related]
36. Defibrillator for primary prevention in congenital heart disease. Sueblinvong V; Ovadia M Pacing Clin Electrophysiol; 2004 Aug; 27(8):1167-9. PubMed ID: 15305972 [TBL] [Abstract][Full Text] [Related]
37. Placement of an implantable cardioverter-defibrillator in an infant with congenital long QT syndrome: anesthetic considerations. Kansara B; Singh A; Kaushal S; Saxena A Ann Card Anaesth; 2011; 14(2):122-6. PubMed ID: 21636934 [TBL] [Abstract][Full Text] [Related]
38. Defibrillation threshold testing: is it necessary during implantable cardioverter-defibrillator implantation? Liu QM; Bai ZL; Liu ZJ; Li XP; Zhou SH Med Hypotheses; 2009 Feb; 72(2):147-9. PubMed ID: 18980811 [TBL] [Abstract][Full Text] [Related]
39. Multiple appropriate and spurious defibrillator shocks in a patient with right ventricular cardiomyopathy. Strohmer B; Schernthaner C; Pichler M Int J Cardiol; 2005 Jul; 102(2):363-6. PubMed ID: 15982515 [TBL] [Abstract][Full Text] [Related]